Education
About Us
Working with TipRanks
Follow Us
Oric Pharmaceuticals (ORIC)
NASDAQ:ORIC
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ -1.03M | $ -966.00K | $ -897.00K | $ -970.00K |
| Operating Income | $ -142.90M | $ -110.78M | $ -91.77M | $ -78.87M | $ -74.19M |
| EBITDA | $ -142.90M | $ -109.75M | $ -91.77M | $ -77.97M | $ -74.19M |
| Net Income | $ -127.85M | $ -100.70M | $ -91.48M | $ -77.68M | $ -97.27M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 255.96M | $ 208.19M | $ 206.27M | $ 236.98M | $ 293.60M |
| Total Assets | $ 274.14M | $ 252.01M | $ 247.18M | $ 298.64M | $ 299.00M |
| Total Debt | $ 3.18M | $ 10.21M | $ 2.66M | $ 1.93M | $ 0.00 |
| Net Debt | $ -59.41M | $ -13.17M | $ -64.18M | $ -224.08M | $ -78.45M |
| Total Liabilities | $ 31.02M | $ 27.92M | $ 24.83M | $ 25.67M | $ 9.22M |
| Stockholders' Equity | $ 243.12M | $ 224.09M | $ 222.35M | $ 272.98M | $ 289.78M |
| Cash Flow | |||||
| Free Cash Flow | $ -112.66M | $ -86.54M | $ -77.22M | $ -60.48M | $ -45.94M |
| Operating Cash Flow | $ -112.66M | $ -85.69M | $ -75.14M | $ -59.54M | $ -45.27M |
| Investing Cash Flow | $ 22.14M | $ -43.40M | $ -109.25M | $ 158.44M | $ -215.96M |
| Financing Cash Flow | $ 126.55M | $ 85.66M | $ 25.62M | $ 49.13M | $ 250.51M |